185 related articles for article (PubMed ID: 10764717)
1. Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.
Chapoutot C; Esslimani M; Joomaye Z; Ramos J; Perney P; Laurent C; Fabbro-Peray P; Larrey D; Domergue J; Blanc F
Gut; 2000 May; 46(5):711-4. PubMed ID: 10764717
[TBL] [Abstract][Full Text] [Related]
2. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
[TBL] [Abstract][Full Text] [Related]
3. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
4. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection.
Chung JW; Shin E; Kim H; Han HS; Cho JY; Choi YR; Hong S; Jang ES; Kim JW; Jeong SH
Liver Int; 2018 May; 38(5):903-914. PubMed ID: 29105340
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
6. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
7. Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma.
Nagasue N; Kolno H; Chang YC; Nakamura T
Oncology; 1989; 46(5):293-6. PubMed ID: 2550861
[TBL] [Abstract][Full Text] [Related]
8. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver.
Turlin B; Juguet F; Moirand R; Le Quilleuc D; Loréal O; Campion JP; Launois B; Ramée MP; Brissot P; Deugnier Y
Hepatology; 1995 Aug; 22(2):446-50. PubMed ID: 7635411
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hepatocellular carcinoma in patients with cirrhosis.
Sarbah SA; Gramlich T; Younoszai A; Osmack P; Goormastic M; Grosso L; Cooper JN; Di Bisceglie A; Seneca R; Younossi ZM
Dig Dis Sci; 2004 May; 49(5):850-3. PubMed ID: 15259508
[TBL] [Abstract][Full Text] [Related]
10. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
11. Detection of micronuclei formation and nuclear anomalies in regenerative nodules of human cirrhotic livers and relationship to hepatocellular carcinoma.
de Almeida TM; Leitão RC; Andrade JD; Beçak W; Carrilho FJ; Sonohara S
Cancer Genet Cytogenet; 2004 Apr; 150(1):16-21. PubMed ID: 15041218
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor levels and lipid peroxidation in hepatocellular carcinoma with hepatitis C virus infection.
Shimizu I; Inoue H; Yano M; Shinomiya H; Wada S; Tsuji Y; Tsutsui A; Okamura S; Shibata H; Ito S
Liver; 2001 Oct; 21(5):342-9. PubMed ID: 11589771
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial damage and iron metabolic dysregulation in hepatitis C virus infection.
Hino K; Nishina S; Sasaki K; Hara Y
Free Radic Biol Med; 2019 Mar; 133():193-199. PubMed ID: 30268888
[TBL] [Abstract][Full Text] [Related]
14. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
15. Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Platelets; 2015; 26(6):577-82. PubMed ID: 25275728
[TBL] [Abstract][Full Text] [Related]
16. African iron overload and hepatocellular carcinoma (HA-7-0-080).
Moyo VM; Makunike R; Gangaidzo IT; Gordeuk VR; McLaren CE; Khumalo H; Saungweme T; Rouault T; Kiire CF
Eur J Haematol; 1998 Jan; 60(1):28-34. PubMed ID: 9451425
[TBL] [Abstract][Full Text] [Related]
17. Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.
Mazzanti R; Messerini L; Comin CE; Fedeli L; Ganne-Carrie N; Beaugrand M
World J Gastroenterol; 2007 Oct; 13(37):5009-14. PubMed ID: 17854145
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
Wang D; Zhang X; Lu Y; Wang X; Zhu L
Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
[TBL] [Abstract][Full Text] [Related]
19. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging.
Ito K; Mitchell DG; Gabata T; Hann HW; Kim PN; Fujita T; Awaya H; Honjo K; Matsunaga N
Radiology; 1999 Jul; 212(1):235-40. PubMed ID: 10405747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
